These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36305225)

  • 41. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.
    Scharf L; Tauriainen J; Buggert M; Hartogensis W; Nolan DJ; Deeks SG; Salemi M; Hecht FM; Karlsson AC
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression analysis of PD-1 and Tim-3 immune checkpoint receptors in patients with vitiligo; positive association with disease activity.
    Rahimi A; Hossein-Nataj H; Hajheydari Z; Aryanian Z; Shayannia A; Ajami A; Asgarian-Omran H
    Exp Dermatol; 2019 Jun; 28(6):674-681. PubMed ID: 31046170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Et tu Mucor?
    Khatri A; Prasai G; Pandey M; Kharel M; Bohara D; Panthi M
    Nepal J Ophthalmol; 2021 Jul; 13(24):177-185. PubMed ID: 35996792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-149-3p reverses CD8
    Zhang M; Gao D; Shi Y; Wang Y; Joshi R; Yu Q; Liu D; Alotaibi F; Zhang Y; Wang H; Li Q; Zhang ZX; Koropatnick J; Min W
    Open Biol; 2019 Oct; 9(10):190061. PubMed ID: 31594465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Highly proliferative and functional PD-1
    Batorov EV; Aristova TA; Pronkina NV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Shevela EY; Ostanin AA; Chernykh ER
    Int Immunopharmacol; 2021 Nov; 100():108093. PubMed ID: 34474273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
    Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
    AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.
    Fleury M; Belkina AC; Proctor EA; Zammitti C; Simms RW; Lauffenburger DA; Snyder-Cappione JE; Lafyatis R; Dooms H
    Arthritis Rheumatol; 2018 Apr; 70(4):566-577. PubMed ID: 29245183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting immune exhaustion during HIV infection.
    Khaitan A; Unutmaz D
    Curr HIV/AIDS Rep; 2011 Mar; 8(1):4-11. PubMed ID: 21188556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Tcell exhaustion based on the expression of EOMES, Tbet and co-inhibitory receptors in severe and non-severe covid-19 patients.
    Saeedifar AM; Ghorban K; Ganji A; Mosayebi G; Gholami M; Dadmanesh M; Rouzbahani NH
    Gene Rep; 2023 Jun; 31():101747. PubMed ID: 36747893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD8
    Lukas Yani S; Keller M; Melzer FL; Weinberger B; Pangrazzi L; Sopper S; Trieb K; Lobina M; Orrù V; Fiorillo E; Cucca F; Grubeck-Loebenstein B
    Front Immunol; 2018; 9():1201. PubMed ID: 29915580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.
    Zahran AM; Hetta HF; Rayan A; Eldin AS; Hassan EA; Fakhry H; Soliman A; El-Badawy O
    Cancer Immunol Immunother; 2020 Jul; 69(7):1253-1263. PubMed ID: 32170378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and phenotypic difference in CD8
    Wang X; He Q; Shen H; Lu XJ; Sun B
    J Med Genet; 2019 Jan; 56(1):18-21. PubMed ID: 29666149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct Immune Profiles of Exhausted Effector and Memory CD8
    Horn S; Borrero-Wolff D; Ritter M; Arndts K; Wiszniewsky A; Debrah LB; Debrah AY; Osei-Mensah J; Chachage M; Hoerauf A; Kroidl I; Layland LE
    Front Cell Infect Microbiol; 2021; 11():680832. PubMed ID: 34485170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural Killer Cells Induce CD8
    Liu S; Xu C; Yang F; Zong L; Qin Y; Gao Y; Su Q; Li T; Li Y; Xu Y; Zheng M
    Front Immunol; 2022; 13():884290. PubMed ID: 35874664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections.
    Mysore KR; Ghobrial RM; Kannanganat S; Minze LJ; Graviss EA; Nguyen DT; Perez KK; Li XC
    Am J Transplant; 2018 Feb; 18(2):351-363. PubMed ID: 29068155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae.
    Wu J; Tang L; Ma Y; Li Y; Zhang D; Li Q; Mei H; Hu Y
    mBio; 2021 Oct; 12(5):e0159921. PubMed ID: 34488453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
    J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
    Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
    J Immunol; 2010 May; 184(9):4696-707. PubMed ID: 20351188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.
    Reddy YM; Yeduguri S; Reddy N VS; Parida S; Kamatham SN; Pidaparthi L; Jaiswal SK; Sadhvani B; Tourani V; Kumar S; Challa S; Murthy JM
    J Mycol Med; 2022 May; 32(2):101252. PubMed ID: 35134736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.